Clinical Trials Logo

Metaplasia clinical trials

View clinical trials related to Metaplasia.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03670134 Withdrawn - Barrett Esophagus Clinical Trials

Predict Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia

Start date: August 6, 2018
Phase: N/A
Study type: Interventional

Researchers are trying to see if the Nvision® Imaging System (VLE) can accurately determine the risk of recurrent Barrett's esophagus in patients with Barrett's esophagus which have been clear of disease.

NCT ID: NCT01859182 Withdrawn - Clinical trials for Advanced Adult Primary Liver Cancer

Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery

Start date: January 2013
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well selumetinib and Akt inhibitor MK-2206 work in treating patients with refractory or advanced gallbladder or bile duct cancer that cannot be removed by surgery. Selumetinib and Akt inhibitor MK-2206 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.